TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, vol.27, no.3, pp.229-235, 2018 (Peer-Reviewed Journal)
OBJECTIVE: We aimed to evaluate the relation of serum Fibroblast Growth Factor 23 (FGF-23), Interleukin 1 beta (IL-1 beta) and Kidney Injury Molecule 1 (KIM-1) levels with progression and mortality rates of patients with CKD at the predialysis stage.